Insider trading

Period: 120 months Stock: EXEL Plan: Scheduled (10b5-1) × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

37 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

37 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

37 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

37 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
37 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
37 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

37 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
10 Aug 2026
Beckerle Mary C Director
Sold on a plan
$526.51K 9,812 at 53.66
37.9%
Planned (10b5-1)
1 Jun 2026
Sold on a plan
$491.97K 9,812 at 50.14
37.9%
Planned (10b5-1)
1 Jun 2026
Sold on a plan
$198.41K 3,925 at 50.55
1.4%
Planned (10b5-1)
18 May 2026
Hefti Brenda SVP and General Counsel
Sold on a plan
$332.64K 6,625 at 50.21
5.8%
Planned (10b5-1)
18 Feb 2026
Sold on a plan
$4.38M 99,574 at 44.01
26.2%
Planned (10b5-1)
18 Feb 2026
Hefti Brenda SVP and General Counsel
Sold on a plan
$821.62K 18,669 at 44.01
16.2%
Planned (10b5-1)
13 Feb 2026
Sold on a plan
$168.85K 3,856 at 43.79
18.0%
Planned (10b5-1)
3 Jun 2025
Sold on a plan
$324.68K 7,535 at 43.09
2.1%
Planned (10b5-1)
2 Jun 2025
Sold on a plan 2×
$805.14K 18,838 at 42.74
46.8%
Planned (10b5-1)
15 May 2025
Haley Patrick J. EVP, Commercial
Sold on a plan 2×
$6.06M 126,383 at 47.96
22.1%
Planned (10b5-1)
14 May 2025
Haley Patrick J. EVP, Commercial
Sold on a plan
$426.80K 10,000 at 42.68
2.0%
Planned (10b5-1)
1 May 2025
Aftab Dana CSO/EVP Disc & Trans Research
Sold on a plan
$58.81K 1,508 at 39.00
0.2%
Planned (10b5-1)
3 Mar 2025
Haley Patrick J. EVP, Commercial
Sold on a plan
$388.00K 10,000 at 38.80
2.8%
Planned (10b5-1)
28 Feb 2025
Sold on a plan
$331.43K 8,768 at 37.80
2.4%
Planned (10b5-1)
14 Feb 2025
Sold on a plan 2×
$405.11K 11,568 at 35.02
27.6%
Planned (10b5-1)
22 Nov 2024
Haley Patrick J. EVP, Commercial
Sold on a plan
$352.70K 10,000 at 35.27
3.5%
Planned (10b5-1)
18 Nov 2024
Haley Patrick J. EVP, Commercial
Sold on a plan 2×
$1.43M 41,588 at 34.36
12.6%
Planned (10b5-1)
5 Nov 2024
Aftab Dana CSO/EVP Disc & Trans Research
Sold on a plan
$3.39M 96,986 at 35.00
16.3%
Planned (10b5-1)
1 Nov 2024
Hessekiel Jeffrey EVP & General Counsel
Sold on a plan
$1.71M 50,000 at 34.13
8.6%
Planned (10b5-1)
30 Oct 2024
Aftab Dana CSO/EVP Disc & Trans Research
Sold on a plan
$36.49K 1,162 at 31.40
0.2%
Planned (10b5-1)
28 Oct 2024
Hessekiel Jeffrey EVP & General Counsel
Sold on a plan
$709.75K 25,000 at 28.39
4.1%
Planned (10b5-1)
23 Sep 2024
Hessekiel Jeffrey EVP & General Counsel
Sold on a plan
$659.50K 25,000 at 26.38
4.0%
Planned (10b5-1)
26 Aug 2024
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$515.80K 20,000 at 25.79
3.1%
Planned (10b5-1)
7 Aug 2024
Aftab Dana CSO/EVP Disc & Trans Research
Sold on a plan
$2.38M 95,000 at 25.00
15.4%
Planned (10b5-1)
7 Aug 2024
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$2.08M 80,000 at 25.97
11.3%
Planned (10b5-1)
7 Aug 2024
Haley Patrick J. EVP, Commercial
Sold on a plan
$357.00K 14,000 at 25.50
3.9%
Planned (10b5-1)
4 Jun 2024
Sold on a plan
$182.31K 8,287 at 22.00
2.3%
Planned (10b5-1)
13 May 2024
Sold on a plan
$233.42K 10,923 at 21.37
3.1%
Planned (10b5-1)
21 Mar 2024
Garber Alan M Director
Sold on a plan
$461.11K 19,205 at 24.01
35.0%
Planned (10b5-1)
14 Dec 2023
Haley Patrick J. EVP, Commercial
Sold on a plan
$1.17M 50,000 at 23.35
14.0%
Planned (10b5-1)
13 Dec 2023
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$575.25K 25,000 at 23.01
4.5%
Planned (10b5-1)
12 Dec 2023
Haley Patrick J. EVP, Commercial
Sold on a plan
$318.35K 14,149 at 22.50
4.4%
Planned (10b5-1)
4 Dec 2023
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$551.50K 25,000 at 22.06
4.3%
Planned (10b5-1)
30 Nov 2023
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$550.25K 25,000 at 22.01
4.1%
Planned (10b5-1)
30 Aug 2023
Aftab Dana CSO/EVP Disc & Trans Research
Sold on a plan
$103.36K 4,600 at 22.47
1.1%
Planned (10b5-1)
1 Aug 2023
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$1.09M 55,710 at 19.63
8.9%
Planned (10b5-1)
5 Apr 2023
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$778.99K 38,930 at 20.01
6.3%
Planned (10b5-1)
Showing 1–37 of 37.